0001225208-24-003052.txt : 20240227
0001225208-24-003052.hdr.sgml : 20240227
20240227134632
ACCESSION NUMBER: 0001225208-24-003052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON RADY A
CENTRAL INDEX KEY: 0001594762
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 24684949
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN CORP. SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 66 HUDSON BOULEVARD EAST
CITY: NEW YORK
STATE: NY
ZIP: 10001-2192
BUSINESS PHONE: 2127332323
MAIL ADDRESS:
STREET 1: 66 HUDSON BOULEVARD EAST
CITY: NEW YORK
STATE: NY
ZIP: 10001-2192
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0508
4
2024-02-23
0000078003
PFIZER INC
PFE
0001594762
JOHNSON RADY A
66 HUDSON BOULEVARD EAST
ATTN: CORPORATE SECRETARY
NEW YORK
NY
10001-2192
1
Executive Vice President
0
Common Stock
2024-02-23
4
M
0
29436.0000
27.3400
A
123073.0000
D
Common Stock
2024-02-23
4
F
0
2132.0000
27.7600
D
120941.0000
D
Common Stock
2024-02-23
4
F
0
23788.0000
27.3700
D
97153.0000
D
Common Stock
6301.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
27.3400
2024-02-23
4
M
0
29436.0000
0.0000
D
2024-02-23
2024-02-23
Common Stock
29436.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Susan E. Grant, by power of atty., for Rady A. Johnson
2024-02-27